After a successful integration and formal SOP (Standard Operating Procedures) inspection of its Russia-based phase one unit, MPR completes the launch of its Rapid Startup Network model to support early phase clinical trials.

​

The Rapid Startup Network includes six units in Michigan, USA (three inpatient, and three outpatient), three units in Jamaica (two inpatient and one outpatient), and one inpatient unit in St. Petersburg, Russia.

​

This model enables sponsors fast access to a large patient population and a rapid startup of their clinical programs, while reducing costs.

​

For more details on MPR RSN and early phase research capabilities, contact Dr. Craig Gordon at craig.gordon@mpr-cro.com